Live Markets »News & Advice»Market News»Market News Details
Market News Details

Aurobindo acquires Apotex's commercial operations in 5 European countries

Press Trust of India/New Delhi 11 Feb 19 | 12:25 PM

Aurobindo Pharma

Aurobindo Pharma on Monday said it has completed the Euro 74-million deal to acquire Apotex's commercial operations and certain supporting infrastructure in five European countries.

Related Stories

    No Related Stories Found
Widgets Magazine

The company had inked a binding agreement on July 14, 2018, to acquire five of Apotex' European businesses, including infrastructure, personnel, products, certain established trademarks, marketing authorisations and dossier licence rights in Poland, the Czech Republic, the Netherlands, Spain and Belgium, Aurobindo Pharma said in a regulatory filing.

ALSO READ: Aurobindo Pharma's Q3 profit surges 19.69% to Rs 712 crore on robust sales

This announcement does not constitute a recommendation to shareholders or potential investors, it added.

Aurobindo Pharma shares were trading 0.94 per cent down at Rs 753.50 apiece on the BSE.

Widgets Magazine


Company Price Gain (%)
Reliance Inds.1,382.902.79
Tata Motors235.902.32
Asian Paints1,465.350.65
Coal India251.750.22


Currently No Poll Available.

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine